Literature DB >> 27026299

The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Carmen Clapp1, Norma Adán2, María G Ledesma-Colunga2, Mariana Solís-Gutiérrez2, Jakob Triebel3, Gonzalo Martínez de la Escalera2.   

Abstract

Rheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory disease destroying articular cartilage and bone. The female preponderance and the influence of reproductive states in RA have long linked this disease to sexually dimorphic, reproductive hormones such as prolactin (PRL). PRL has immune-enhancing properties and increases in the circulation of some patients with RA. However, PRL also suppresses the immune system, stimulates the formation and survival of joint tissues, acquires antiangiogenic properties upon its cleavage to vasoinhibins, and protects against joint destruction and inflammation in the adjuvant-induced model of RA. This review addresses risk factors for RA linked to PRL, the effects of PRL and vasoinhibins on joint tissues, blood vessels, and immune cells, and the clinical and experimental data associating PRL with RA. This information provides important insights into the pathophysiology of RA and highlights protective actions of the PRL/vasoinhibin axis that could lead to therapeutic benefits.

Entities:  

Keywords:  Angiogenesis; Blood vessels; Bone; Cartilage; Gender; Immune cells; Joint tissues; Reproduction; Stress

Mesh：

Substances：

Year:  2016        PMID： 27026299     DOI： 10.1007/s00018-016-2187-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


  264 in total

Review 1.  A novel megakaryocyte differentiation factor from mouse placenta.

Authors:  J Lin; D I Linzer
Journal:  Trends Cardiovasc Med       Date:  1999-08       Impact factor: 6.677

Review 2.  Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Nat Clin Pract Rheumatol       Date:  2008-03

3.  The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis.

Authors:  T D Spector; M C Hochberg
Journal:  Br J Rheumatol       Date:  1989

4.  Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies.

Authors:  Caroline Kaercher Kramer; Tatiana Freitas Tourinho; Waldir Pedro de Castro; Miriam da Costa Oliveira
Journal:  Arch Med Res       Date:  2005 Jan-Feb       Impact factor: 2.235

5.  Studies of acute effect of prolactin on distribution of absorbed calcium and long-term effect on calcium balance in weaned, young, and sexually mature rats.

Authors:  N Krishnamra; V Cheeveewattana
Journal:  Can J Physiol Pharmacol       Date:  1994-12       Impact factor: 2.273

6.  The role of bromocriptine in the treatment of patients with active rheumatoid arthritis.

Authors:  Mansour Salesi; Somayeh Sadeghihaddadzavareh; Peyman Nasri; Nasrin Namdarigharaghani; Ziba Farajzadegan; Mehri Hajalikhani
Journal:  Int J Rheum Dis       Date:  2013-01-18       Impact factor: 2.454

7.  Uterine natural killer cells are targets for a trophoblast cell-specific cytokine, prolactin-like protein A.

Authors:  H Müller; B Liu; B A Croy; J R Head; J S Hunt; G Dai; M J Soares
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

8.  The comparative study of Sprague-Dawley and Lewis rats in adjuvant-induced arthritis.

Authors:  X Cai; Y F Wong; H Zhou; Y Xie; Z Q Liu; Z H Jiang; Z X Bian; H X Xu; L Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-26       Impact factor: 3.000

9.  The short prolactin receptor predominates in endothelial cells of micro- and macrovascular origin.

Authors:  Albert M Ricken; Anja Traenkner; Claudia Merkwitz; Katja Hummitzsch; Jens Grosche; Katharina Spanel-Borowski
Journal:  J Vasc Res       Date:  2006-12-11       Impact factor: 1.934

10.  Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes.

Authors:  Alfredo Leaños-Miranda; Janeth Márquez-Acosta; Guadalupe María Cárdenas-Mondragón; Zarela Lizbeth Chinolla-Arellano; Roxana Rivera-Leaños; Sara Bermejo-Huerta; Juan Fernando Romero-Arauz; Guadalupe Alvarez-Jiménez; Julio César Ramos-León; Alfredo Ulloa-Aguirre
Journal:  J Clin Endocrinol Metab       Date:  2008-05-06       Impact factor: 5.958
View more
  11 in total

1.  Association between sexual maturation and anterior disc displacement of temporomandibular joint in adolescents aged 13-14 years.

Authors:  Pei Shen; Dahe Zhang; Ahmed Abdelrehem; Shan Jin; Yi Luo; Chi Yang
Journal:  Clin Oral Investig       Date:  2022-09-14       Impact factor: 3.606

Review 2.  Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis.

Authors:  Carmen Clapp; Georgina Ortiz; Jose F García-Rodrigo; María G Ledesma-Colunga; Oscar F Martínez-Díaz; Norma Adán; Gonzalo Martínez de la Escalera
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

3.  Vasoinhibin is Generated and Promotes Inflammation in Mild Antigen-induced Arthritis.

Authors:  Georgina Ortiz; Maria G Ledesma-Colunga; Zhijian Wu; Jose F García-Rodrigo; Norma Adan; Oscar F Martinez-Diaz; Ericka A De Los Ríos; Fernando López-Barrera; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

Review 4.  From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

Authors:  Jakob Triebel; Maria Ludivina Robles-Osorio; Renata Garcia-Franco; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-11       Impact factor: 5.555

Review 5.  Osteoarthritis and the Complement Cascade.

Authors:  Sandeep Silawal; Jakob Triebel; Thomas Bertsch; Gundula Schulze-Tanzil
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2018-01-03

6.  Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.

Authors:  Maria G Ledesma-Colunga; Norma Adán; Georgina Ortiz; Mariana Solís-Gutiérrez; Fernando López-Barrera; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Arthritis Res Ther       Date:  2017-05-15       Impact factor: 5.156

Review 7.  Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis.

Authors:  Man W Tang; Samuel Garcia; Danielle M Gerlag; Paul P Tak; Kris A Reedquist
Journal:  Front Immunol       Date:  2017-06-23       Impact factor: 7.561

Review 8.  Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes.

Authors:  Nicola Chiarelli; Marco Ritelli; Nicoletta Zoppi; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-08-12       Impact factor: 4.096

Review 9.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

Review 10.  The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders.

Authors:  Eugenia Bertoldo; Giovanni Adami; Maurizio Rossini; Alessandro Giollo; Giovanni Orsolini; Ombretta Viapiana; Davide Gatti; Angelo Fassio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.